etoposide has been researched along with HTLV-I Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, H; Ambinder, R; Barta, SK; Baydoun, HH; Caruso, B; Cheng, X; Harding, J; Jacobson, S; Noy, A; Parekh, S; Phillips, A; Ramos, JC; Ratner, L; Rauch, D | 1 |
| Tsukasaki, K | 1 |
| Becker, N; Leaf, A; Sparano, JA; Strack, M; Valentine, ES; Wiernik, PH | 1 |
| Fukuda, N; Muraki, K; Ota, I; Shimohakamada, Y; Shinohara, K | 1 |
1 review(s) available for etoposide and HTLV-I Infections
| Article | Year |
|---|---|
Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma.
Topics: Acute Disease; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Lymphoma, T-Cell, Cutaneous; Male; Nitrosourea Compounds; Prednisolone; Proviruses; Radiotherapy; Remission Induction; Translocation, Genetic; Vincristine | 2002 |
3 other study(ies) available for etoposide and HTLV-I Infections
| Article | Year |
|---|---|
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Etoposide; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Prednisone; Raltegravir Potassium; Treatment Outcome; Vincristine | 2016 |
Adult T-cell leukemia-lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2012 |
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV; HIV Infections; HIV Seropositivity; HTLV-I Infections; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors | 1993 |